Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.69
0.021.2%
Last update: Oct 16, 7:44 AM
$1.73
0.063.59%
Acumen Pharmaceuticals Inc (ABOS) Stock Price, Quote, News & History
ABOSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Acumen Pharmaceuticals has a consensus price target of $7.29.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $1.73 last updated October 16, 2026 at 7:44 AM EDT.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
